Latin America Pharmaceutical Contract Manufacturing & Research Services Markrt

According to a recent report by Grand View Research, Inc., the pharmaceutical contract manufacturing and research services market in Latin America is projected to reach a total value of USD 40.3 billion by the year 2030. This market is expected to grow at a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2023 to 2030. Several core factors are fueling this growth, most notably the relatively low manufacturing costs across the region and the increasing demand for generic pharmaceutical products. These elements make Latin America an attractive destination for pharmaceutical companies seeking cost-effective production and research partnerships. Additionally, the expansion of the pharmaceutical sector, rising levels of investment in research and development (R&D), and continuous technological advancements in drug development and manufacturing processes are all contributing significantly to the market’s upward trajectory.

Further driving market growth is a notable industry shift from basic cost-cutting strategies to more sophisticated, value-added solutions. This shift includes the emergence of modern, technologically advanced manufacturing and research facilities, as well as an increased willingness among pharmaceutical companies to engage in risk-sharing partnerships with contract manufacturing organizations (CMOs) and contract research organizations (CROs). These collaborations are becoming more strategic, with companies leveraging the expertise and infrastructure of contract service providers to enhance product quality, improve efficiency, and reduce time to market.

To address the growing global and regional demand for biological drugs, pharmaceutical companies have begun increasing their investments in biologics development. This trend is expected to further fuel the growth of pharmaceutical contract services in Latin America. The continued commercial success of biopharmaceuticals—including monoclonal antibodies, vaccines, and biosimilars—is encouraging greater outsourcing of development and manufacturing activities, thus supporting market expansion throughout the forecast period.

In Brazil, one of the largest pharmaceutical markets in Latin America, contract manufacturing and research services are governed by stringent regulatory frameworks. Companies must comply with rigorous Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) to ensure product safety, quality, and efficacy. These regulatory standards encompass various operational aspects, including facility design and maintenance, robust quality control systems, accurate documentation procedures, and the appropriate training and qualifications of personnel.

To operate legally, contract service providers must obtain certifications and authorizations from Brazil’s National Health Surveillance Agency (ANVISA). This involves a comprehensive review and inspection of their manufacturing plants, laboratory processes, and overall quality management systems to ensure full regulatory compliance.

Curious about the Latin America Pharmaceutical Contract Manufacturing & Research Services Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Here are some commonly asked questions related to the Latin America Pharmaceutical Contract Manufacturing & Research Services Market, along with answers that provide essential insights.

1. How big is the Latin America pharmaceutical contract manufacturing and research services market?

The Latin America pharmaceutical contract manufacturing and research services market size was estimated at USD 22.50 billion in 2022 and is expected to reach USD 24.3 billion in 2023.

2. What is the Latin America pharmaceutical contract manufacturing and research services market growth?

The Latin America pharmaceutical contract manufacturing and research services market is expected to grow at a compound annual growth rate of 7.46% from 2023 to 2030 to reach USD 40.3 billion by 2030.

3. Which segment accounted for the largest Latin America pharmaceutical contract manufacturing and research services market share?

Brazil dominated the Latin America pharmaceutical contract manufacturing and research services market with a share of 69.44% in 2021. This is attributable to the developing biotechnology hub, the presence of numerous GMP-certified plants, and low manufacturing costs attracting investors from other regions to establish their presence in this country.

4. Who are the key players in the Latin America pharmaceutical contract manufacturing and research services market?

Some key players operating in the Latin America pharmaceutical contract manufacturing and research services market include Boehringer Ingelheim GmbH, Fresenius Kabi AG, Unither Pharmaceuticals, Lonza, Charles River Laboratories International, Inc, Laboratory Corporation of America Holdings, IQVIA

5. What are the factors driving the Latin America pharmaceutical contract manufacturing and research services market?

Key factors that are driving the Latin America pharmaceutical contract manufacturing and research services market growth include drug shortfall, rising competition, tighter budgets, insufficient resources, and patent expiration.

Order a free sample PDF of the Latin America Pharmaceutical Contract Manufacturing & Research Services Market Intelligence Study, published by Grand View Research.